Moderna, Inc. (MRNA)

Company snapshot

Ticker

MRNA

Exchange

NMS

Sector

Healthcare

Industry

Biotechnology

Market cap

$74.84B

Employees

4,700

Currency

USD

Website

https://www.modernatx.com

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial…

Latest coverage

• Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
  October 13, 2026
• Why Moderna Stock Surged Today
  October 10, 2026
• This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street
  October 9, 2026
• Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?
  October 8, 2026
• Is Now the Time to Cash Out of the S&P 500’s Top 3 Stocks of 2026?
  October 6, 2026